ConductScience.org, home

Paper110888

Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa.

Pennington JE. J Infect Dis, 1979. Cited by 52 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa. Papers, record 110888. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/110888

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa.
PubMed
Journal
J Infect Dis
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pennington JEJ E

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial VaccinesMajor topic
Disease Models, AnimalMajor topic
LipopolysaccharidesMajor topic
PneumoniaMajor topic
Pseudomonas aeruginosaMajor topic
Animals
Antibodies, Bacterial
Guinea Pigs
Lung

Source PubMed

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
31,106,270Macrophage centripetal migration drives spontaneous healing process after spinal cord injury.Sci Adv2019https://conductscience.org/library/papers/31106270PubMed
10,489,698Pseudomonas aeruginosa phage lysate as an immunobiological agent. 1. Selection of Pseudomonas aeruginosa clinical strains for phage lysate preparation.Folia Microbiol (Praha)1999https://conductscience.org/library/papers/10489698PubMed
7,216,441Intranasal immunization of mice against Pasteurella multocida.Infect Immun1981https://conductscience.org/library/papers/7216441PubMed
6,816,585Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.Eur J Clin Microbiol1982https://conductscience.org/library/papers/6816585PubMed
6,816,583Serum-induced lysis of Pseudomonas aeruginosa.Eur J Clin Microbiol1982https://conductscience.org/library/papers/6816583PubMed
6,815,088Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation.Infect Immun1982https://conductscience.org/library/papers/6815088PubMed
6,795,229Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.J Clin Invest1981https://conductscience.org/library/papers/6795229PubMed
6,792,080Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.Infect Immun1981https://conductscience.org/library/papers/6792080PubMed
6,788,696Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs.Infect Immun1981https://conductscience.org/library/papers/6788696PubMed
6,783,532Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.Infect Immun1980https://conductscience.org/library/papers/6783532PubMed
6,698,608Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.Infect Immun1984https://conductscience.org/library/papers/6698608PubMed
6,404,823Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.Infect Immun1983https://conductscience.org/library/papers/6404823PubMed
6,401,692Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.Infect Immun1983https://conductscience.org/library/papers/6401692PubMed
3,918,939Decreased delayed-type hypersensitivity and increased protection to Listeria monocytogenes seen in mice infected with mucoid and nonmucoid Pseudomonas aeruginosa.Infect Immun1985https://conductscience.org/library/papers/3918939PubMed
3,116,355Lung mechanics, gas exchange, pulmonary perfusion, and hemodynamics in a canine model of acute Pseudomonas pneumonia.Lung1987https://conductscience.org/library/papers/3116355PubMed
3,102,378Suppression of the delayed-type hypersensitivity and cell-mediated immune responses to Listeria monocytogenes induced by Pseudomonas aeruginosa.Infect Immun1987https://conductscience.org/library/papers/3102378PubMed
3,093,385Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.Infect Immun1986https://conductscience.org/library/papers/3093385PubMed
3,082,756Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.Infect Immun1986https://conductscience.org/library/papers/3082756PubMed
1,898,896A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.Infect Immun1991https://conductscience.org/library/papers/1898896PubMed
1,500,165Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.Infect Immun1992https://conductscience.org/library/papers/1500165PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/110888

GET https://conductscience.org/api/papers/v1/110888/cited_by?page=2